[Functional role of the nucleus accumbens in the control of the activity of the substantia nigra].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9704140)

Published in Boll Soc Ital Biol Sper on March 30, 1983

Authors

E Campana, G Fiadone, A Gasbarri, D Civitelli

Articles by these authors

Thyroid disease classification. Lancet (2000) 2.00

Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet (2001) 1.54

Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res (1994) 1.43

Anterograde and retrograde tracing of projections from the ventral tegmental area to the hippocampal formation in the rat. Brain Res Bull (1994) 1.37

Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD. Neurology (1999) 1.05

Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis. Am J Hum Genet (1993) 1.00

Pedunculopontine-evoked excitation of substantia nigra neurons in the rat. Brain Res (1984) 0.94

Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency in south-east Sicily. Ann Hum Genet (1997) 0.88

DJ-1 is a Parkinson's disease susceptibility gene in southern Italy. Clin Genet (2009) 0.87

A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat. Exp Brain Res (1986) 0.86

SIL1 and SARA2 mutations in Marinesco-Sjögren and chylomicron retention diseases. Clin Genet (2007) 0.84

The effect of intrastriatal injection of liposome-entrapped tyrosinase on the dopamine levels in the rat brain. Cell Mol Biol (Noisy-le-grand) (1999) 0.83

Association of tau gene polymorphism with Parkinson's disease. Neurol Sci (2003) 0.83

Clinical importance of thrombomodulin serum levels. Eur Rev Med Pharmacol Sci (2001) 0.83

Oxygen uptake, heart rate and blood lactate concentration during a normal training session of an aerobic dance class. Eur J Appl Physiol Occup Physiol (1998) 0.82

Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products. Am J Pathol (1999) 0.82

Task-dependent role for dorsal striatum metabotropic glutamate receptors in memory. Learn Mem (2001) 0.82

The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease. Mov Disord (2000) 0.81

NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy. Neurosci Lett (2003) 0.81

Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD. Neurology (2001) 0.81

A hypofibrinolytic state in overweight patients with cerebral venous thrombosis and isolated intracranial hypertension. J Neurol (1999) 0.81

The organization of nucleus tegmenti pedunculopontinus neurons projecting to basal ganglia and thalamus: a retrograde fluorescent double labeling study in the rat. Neurosci Lett (1987) 0.80

Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 0.80

LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease. Clin Genet (2007) 0.78

Strain-dependent involvement of D1 and D2 dopamine receptors in muscarinic cholinergic influences on memory storage. Behav Brain Res (1999) 0.78

ET-1 plasma levels during cold stress test in sclerodermic patients. Angiology (1997) 0.78

A case of chronic adrenocortical insufficiency with iatrogenic anasarca. Adv Ther (2000) 0.78

Angiomyofibroblastoma and aggressive angiomyxoma: two benign mesenchymal neoplasms of the female genital tract. An immunohistochemical study. Pathol Res Pract (1999) 0.77

Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease. Hum Genet (2007) 0.77

[Projections of the Tsai tegmental ventral area to the hippocampus: a study of the rat using the Fink-Heimer technic]. Boll Soc Ital Biol Sper (1989) 0.77

Effects of d-amphetamine on short- and long-term memory in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Behav Brain Res (2010) 0.77

Novel human pathological mutations. Gene symbol: SCN1A. Disease: Myoclonic epilepsy of infancy. Hum Genet (2010) 0.76

CGRP and ET-1 plasma levels in normal subjects. Eur Rev Med Pharmacol Sci (2000) 0.76

The relationship between glycated hemoglobin and polymorphonuclear leukocyte leukotriene B4 release in people with diabetes mellitus. Diabetes Res Clin Pract (1999) 0.76

Organization of the projections from the ventral tegmental area of Tsai to the hippocampal formation in the rat. J Hirnforsch (1991) 0.76

Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease. Hum Genet (2007) 0.76

Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease. Hum Genet (2007) 0.75

[Calcitonin gene-related peptide in diabetes mellitus type 2: a possible etiopathogenetic role]. Riv Eur Sci Med Farmacol (1996) 0.75

[Organization of the direct projections of the Tsai ventral tegmental area to the hippocampus]. Boll Soc Ital Biol Sper (1989) 0.75

Novel human pathological mutations. Gene symbol: SCN1A. Disease: severe myoclonic epilepsy of infancy. Hum Genet (2009) 0.75

ET-1 levels in cardioischemic patients undergoing atrial pacing. J Med (2001) 0.75

Plasma atrial natriuretic hormone in hyperthyroidism. Endocr Res (1998) 0.75

Gene dosage influences the age at onset of SCA2 in a family from southern Italy. Clin Genet (2007) 0.75

Electrophysiological evidence for an inhibitory accumbens-entopeduncular pathway in the rat. Neurosci Lett (1982) 0.75

[Use of diverse diagnostic techniques in the study of silicosis]. G Ital Med Lav Ergon (2000) 0.75

Anti-neutrophil cell antibodies in newly diagnosed patients with type-1-diabetes. Exp Clin Endocrinol Diabetes (1999) 0.75

The functional role of the nucleus accumbens in the control of the substantia nigra: electrophysiological investigations in intact and striatum-globus pallidus lesioned rats. Brain Res (1983) 0.75

Coronary sinus plasma beta endorphin levels in cardioischemic patients undergoing PTCA. J Med (1998) 0.75

Novel human pathological mutations. Gene symbol: PARK7. Disease: Parkinson disease. Hum Genet (2010) 0.75

[The endothelium]. Riv Eur Sci Med Farmacol (1996) 0.75

Met-enkephalin levels during PTCA-induced myocardial ischemia. Peptides (2001) 0.75

Effects of the retrorubral field stimulation on the excitability of the rat hippocampus in vivo. Neurosci Lett (1996) 0.75

[Molecular diagnosis of synovial sarcoma]. Pathologica (2002) 0.75

[Heat shock proteins in diabetes mellitus]. Riv Eur Sci Med Farmacol (1996) 0.75

Mitral prolapse. A heart anomaly in a clinical neuroendocrine context. Minerva Cardioangiol (2000) 0.75

[Electrophysiological evidence of a nucleus accumbens/entopeduncular nucleus inhibitory pathway]. Boll Soc Ital Biol Sper (1983) 0.75

The role of met-enkephalin in silent myocardial ischemia in diabetic patients. J Med (2001) 0.75

Increased plasma concentration of atrial natriuretic hormone in myotonic dystrophy. Eur Neurol (1998) 0.75

[Endothelium and diabetes: study of plasma levels of endothelin-1 in diabetic patients with arterial hypertension or proliferative retinopathy]. Minerva Med (1995) 0.75

Neuroexcitatory properties of kainic acid. II) Neuronal damages following intracerebreal microinjections in behavioural rats. Boll Soc Ital Biol Sper (1981) 0.75

[Comparison of the growth of subjects from 6 to 12 years of age in the province of Naples and the province of L'Aquila]. Boll Soc Ital Biol Sper (1982) 0.75

Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease. Hum Genet (2007) 0.75

Novel human pathological mutations. Gene symbol: PINK1. Disease: Parkinson disease. Hum Genet (2010) 0.75

A new technology in the diagnosis of small ventricular septal defects. J Obstet Gynaecol (2012) 0.75

Adrenomedullin assay and its clinical significance. Eur Rev Med Pharmacol Sci (2000) 0.75